
Findings presented at the Heidelberg 2025 International SPECTRALIS Symposium — And Beyond (ISS) suggest detailed structural data could better inform therapeutic targeting and monitoring.
Karl Csaky, MD, PhD, is a vitreoretinal specialist serving as the chief executive and medical officer at the Retina Foundation of the Southwest in Dallas, Texas.
Findings presented at the Heidelberg 2025 International SPECTRALIS Symposium — And Beyond (ISS) suggest detailed structural data could better inform therapeutic targeting and monitoring.
Published: June 13th 2025 | Updated: